Currently, Namodenoson is being evaluated in a pivotal Phase 3 multinational registrational trial for the treatment of ...

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Agenus (AGEN – Research Report) today and set a price target of $11.00.Stay ...

In addition to design and training, immersive technologies are making significant strides in marketing and promotion. For instance, ASCO Power Technologies, a leader in power solutions, has ...

Stifel Nicolaus analyst Benjamin Burnett has maintained their bullish stance on PGEN stock, giving a Buy rating today.Don't Miss Our New ...

ASCO commits to collaborating with the ICC site over a period ... These solutions may include implementing new technologies, improving care coordination processes, or enhancing the accessibility of ...

ASCO GI is one of the most influential global conferences ... Although mRNA has advantages such as rapid development speed ...

Last month, the American Society of Clinical Oncology (ASCO) had its Annual Meeting ... thereby allowing for more informed decision-making. These technologies can help identify potential issues ...

Advancing gastrointestinal cancer pipeline underscores potential for additional registration-enabling studies SAN DIEGO and CALGARY, AB, Dec. /PRNewswire/ -- Oncolytics B ...

Dr is providing care to patients at the FCS Lake Mary Cancer Center , Deland and Orange City locations. John Bollinger, MD ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...